Literature DB >> 11255730

Metastatic osteosarcoma to the liver after treatment for synovial sarcoma: a case report.

N C Daw1, S C Kaste, D A Hill, L E Kun, C B Pratt.   

Abstract

Metastatic osteosarcoma most commonly affects the lungs and other bones. Hepatic metastasis at the time of diagnosis is extremely rare. A 14-year-old boy with synovial sarcoma of the left popliteal fossa was treated with surgical resection, radiotherapy for microscopic residual disease, and 1 year of chemotherapy (vincristine, cyclophosphamide, dactinomycin, and doxorubicin). Approximately 10 years after the initial diagnosis, a secondary osteosarcoma developed in the left proximal tibia. Computed tomography at presentation showed bilateral pulmonary metastases and large ossified nodules in the liver that demonstrated abnormal avidity on 99mTc MDP bone scan indicating hepatic metastasis. Despite chemotherapy (cisplatin, ifosfamide, high-dose methotrexate, and dacarbazine), the patient died of progressive disease 4 months after the diagnosis of the second cancer. Hepatic metastasis was found at the time of diagnosis of a secondary osteosarcoma and manifested as ossified nodules. The risk of radiation-induced osteosarcoma should always be considered in decisions about treatment for soft-tissue sarcoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255730     DOI: 10.1080/088800101300002955

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  4 in total

1.  Metastatic osteosarcoma to the liver and the kidney: a case report and review of the literature.

Authors:  Wen-Xi Yu; Yang Yao
Journal:  BMJ Case Rep       Date:  2009-02-26

2.  Hepatic metastatic disease in pediatric and adolescent solid tumors.

Authors:  Israel Fernandez-Pineda; John A Sandoval; Andrew M Davidoff
Journal:  World J Hepatol       Date:  2015-07-18

3.  Pigment Epithelium Derived Factor Is Involved in the Late Phase of Osteosarcoma Metastasis by Increasing Extravasation and Cell-Cell Adhesion.

Authors:  Sei Kuriyama; Gentaro Tanaka; Kurara Takagane; Go Itoh; Masamitsu Tanaka
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

4.  Shilajit potentiates the effect of chemotherapeutic drugs and mitigates metastasis induced liver and kidney damages in osteosarcoma rats.

Authors:  Ebtihaj J Jambi; Fawzia Abdulaziz Alshubaily
Journal:  Saudi J Biol Sci       Date:  2022-07-25       Impact factor: 4.052

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.